Comparison of Oral Paracetamol versus Ibuprofen in Premature Infants with Patent Ductus Arteriosus: A Randomized Controlled Trial

Failure of a repeat course of cyclooxygenase inhibitor to close a PDA is a risk factor for developing chronic lung disease in ELBW infants

(2012) Lynda Adrouche-Amrani et al.   BMC Pediatrics

Patent ductus arteriosus: patho-physiology, hemodynamic effects and clinical complications

(2012) Giovanbattista Capozzi et al.   Journal of Maternal-Fetal & Neonatal Medicine

A different first-choice drug in the medical management of patent ductus arteriosus: oral paracetamol

(2012) Sadik Yurttutan et al.   Journal of Maternal-Fetal & Neonatal Medicine

Oral versus intravenous ibuprofen for patent ductus arteriosus closure: a randomised controlled trial in extremely low birthweight infants

(2011) Omer Erdeve et al.   Archives of Disease in Childhood-Fetal and Neonatal Edition

Gastrointestinal complications associated with ibuprofen therapy for patent ductus arteriosus

(2011) R Rao et al.   Journal of Perinatology

Ductal Closure With Paracetamol: A Surprising New Approach to Patent Ductus Arteriosus Treatment

(2011) C. Hammerman et al.   PEDIATRICS

Relationship between Circulating Platelet Counts and Ductus Arteriosus Patency after Indomethacin Treatment

(2010) Nidhi A. Shah et al.   JOURNAL OF PEDIATRICS

Efficacy and Safety of Oral Versus Intravenous Ibuprofen in Very Low Birth Weight Preterm Infants with Patent Ductus Arteriosus

(2010) Tulin Gokmen et al.   JOURNAL OF PEDIATRICS

Displacement of Bilirubin From Albumin by Ibuprofen In Vitro

(2010) Hanne T Soligard et al.   PEDIATRIC RESEARCH

Does Ibuprofen Increase Neonatal Hyperbilirubinemia?

(2009) E. Zecca et al.   PEDIATRICS

Total serum bilirubin levels during cyclooxygenase inhibitor treatment for patent ductus arteriosus in preterm infants

(2008) C Rheinlaender et al.   ACTA PAEDIATRICA